News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
641,260 Results
Type
Article (49325)
Company Profile (402)
Press Release (591532)
Multimedia
Podcasts (111)
Webinars (16)
Section
Business (167898)
Career Advice (3096)
Deals (30875)
Drug Delivery (104)
Drug Development (79533)
Employer Resources (175)
FDA (15528)
Job Trends (13419)
News (300388)
Policy (29825)
Tag
Academia (2751)
Academic (1)
Accelerated approval (10)
Adcomms (32)
Allergies (100)
Alliances (44998)
ALS (115)
Alzheimer's disease (1517)
Antibody-drug conjugate (ADC) (174)
Approvals (15495)
Artificial intelligence (323)
Autoimmune disease (35)
Automation (17)
Bankruptcy (293)
Best Places to Work (10918)
BIOSECURE Act (18)
Biosimilars (116)
Biotechnology (309)
Bladder cancer (97)
Brain cancer (38)
Breast cancer (376)
Cancer (2958)
Cardiovascular disease (228)
Career advice (2613)
Career pathing (33)
CAR-T (207)
CDC (30)
Cell therapy (562)
Cervical cancer (21)
Clinical research (65215)
Collaboration (1060)
Company closure (3)
Compensation (647)
Complete response letters (29)
COVID-19 (2596)
CRISPR (66)
C-suite (326)
Cystic fibrosis (119)
Data (3014)
Decentralized trials (2)
Denatured (34)
Depression (68)
Diabetes (357)
Diagnostics (6148)
Digital health (23)
Diversity (7)
Diversity, equity & inclusion (44)
Drug discovery (150)
Drug pricing (124)
Drug shortages (32)
Duchenne muscular dystrophy (132)
Earnings (64405)
Editorial (48)
Employer branding (21)
Employer resources (154)
Events (107944)
Executive appointments (814)
FDA (17152)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (949)
Gene editing (142)
Generative AI (27)
Gene therapy (432)
GLP-1 (839)
Government (4493)
Grass and pollen (5)
Guidances (163)
Healthcare (18198)
Huntington's disease (30)
IgA nephropathy (43)
Immunology and inflammation (170)
Immuno-oncology (9)
Indications (39)
Infectious disease (2765)
Inflammatory bowel disease (159)
Inflation Reduction Act (13)
Influenza (61)
Intellectual property (121)
Interviews (604)
IPO (14786)
IRA (47)
Job creations (2923)
Job search strategy (2136)
Kidney cancer (12)
Labor market (50)
Layoffs (477)
Leadership (25)
Legal (6361)
Liver cancer (76)
Lung cancer (416)
Lymphoma (209)
Machine learning (11)
Management (62)
Manufacturing (391)
MASH (95)
Medical device (11818)
Medtech (11821)
Mergers & acquisitions (16845)
Metabolic disorders (895)
Multiple sclerosis (97)
NASH (21)
Neurodegenerative disease (127)
Neuropsychiatric disorders (39)
Neuroscience (2226)
NextGen: Class of 2025 (6338)
Non-profit (4352)
Now hiring (39)
Obesity (454)
Opinion (275)
Ovarian cancer (101)
Pain (117)
Pancreatic cancer (114)
Parkinson's disease (192)
Partnered (21)
Patents (296)
Patient recruitment (161)
Peanut (52)
People (49528)
Pharmaceutical (77)
Pharmacy benefit managers (23)
Phase I (20498)
Phase II (28865)
Phase III (21457)
Pipeline (1623)
Policy (214)
Postmarket research (2343)
Preclinical (8798)
Press Release (69)
Prostate cancer (148)
Psychedelics (42)
Radiopharmaceuticals (274)
Rare diseases (509)
Real estate (5346)
Recruiting (71)
Regulatory (21499)
Reports (39)
Research institute (2421)
Resumes & cover letters (495)
Rett syndrome (10)
RNA editing (10)
RSV (47)
Schizophrenia (95)
Series A (160)
Series B (111)
Service/supplier (8)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (36)
Startups (3296)
State (2)
Stomach cancer (17)
Supply chain (75)
Tariffs (52)
The Weekly (76)
Vaccines (761)
Venture capital (55)
Weight loss (289)
Women's health (37)
Worklife (20)
Date
Last 7 days (363)
Last 30 days (1787)
Last 365 days (31175)
2025 (16723)
2024 (34977)
2023 (39238)
2022 (49630)
2021 (53825)
2020 (51706)
2019 (44142)
2018 (33424)
2017 (31178)
2016 (30676)
2015 (35248)
2014 (27578)
2013 (22605)
2012 (23796)
2011 (24420)
2010 (22262)
Location
Africa (859)
Alabama (64)
Alaska (6)
Arizona (181)
Arkansas (14)
Asia (37720)
Australia (6576)
California (7258)
Canada (2292)
China (690)
Colorado (311)
Connecticut (318)
Delaware (190)
Europe (87791)
Florida (1069)
Georgia (236)
Hawaii (1)
Idaho (53)
Illinois (638)
India (27)
Indiana (322)
Iowa (15)
Japan (218)
Kansas (107)
Kentucky (28)
Louisiana (15)
Maine (61)
Maryland (969)
Massachusetts (5610)
Michigan (240)
Minnesota (421)
Mississippi (2)
Missouri (87)
Montana (28)
Nebraska (22)
Nevada (67)
New Hampshire (63)
New Jersey (2040)
New Mexico (30)
New York (2053)
North Carolina (1105)
North Dakota (9)
Northern California (3176)
Ohio (233)
Oklahoma (16)
Oregon (34)
Pennsylvania (1571)
Puerto Rico (15)
Rhode Island (35)
South America (1149)
South Carolina (31)
Southern California (2711)
Tennessee (99)
Texas (1071)
United States (27012)
Utah (195)
Virginia (181)
Washington D.C. (67)
Washington State (645)
West Virginia (4)
Wisconsin (64)
641,260 Results for "the jackson laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Astoriom Appoints Brittany Jackson as CFO
June 17, 2025
·
2 min read
Business
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery
The Jackson Laboratory, an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.
May 10, 2024
·
3 min read
Business
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
The Jackson Laboratory and LG AI Research signed a partnership agreement creating an alliance between JAX’s longstanding expertise in biomedical research and data analysis and LG’s AI research and product development prowess.
March 11, 2024
·
4 min read
Press Releases
Jackson Pharmacy Professionals Unveils Brand Refresh and New Identity as “Jackson PharmacyPros”
December 11, 2024
·
2 min read
Business
The Jackson Laboratory names Meghan Finn Vice President and Chief Communications Officer
Meghan Finn has joined The Jackson Laboratory, an independent, nonprofit biomedical research institution, as Vice President and Chief Communications Officer.
September 20, 2023
·
2 min read
Genetown
New research from The Jackson Laboratory: variable patient responses to SARS-CoV-2 infection are mimicked in genetically diverse mice
Researchers at The Jackson Laboratory have created a panel of genetically diverse mice that accurately model the highly variable human response to SARS-CoV-2 infection.
August 11, 2023
·
4 min read
Business
The Jackson Laboratory appoints Gina Rodriguez as its new vice president of advancement
The Jackson Laboratory has appointed Gina Rodriguez as vice president of advancement. Rodriguez will lead the Laboratory’s advancement team and be responsible for philanthropic efforts in support of JAX’s mission to improve human health.
February 14, 2023
·
2 min read
Business
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
Calidi Biotherapeutics, Inc. today announced the appointment of Andrew Jackson as Chief Financial Officer.
October 30, 2023
·
3 min read
Press Releases
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
June 2, 2025
·
3 min read
Business
SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors
SEED Therapeutics, a BeyondSpring subsidiary and global research company focused on harnessing and engineering “molecular glues,” a targeted protein degradation platform to attack previously believed undruggable targets, announced that it has appointed Jackson Tai to its Board of Directors.
June 20, 2023
·
3 min read
1 of 64,126
Next
